The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G, and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Environment Sustainability in Medical Devices: Bio-active prosthesis sealing.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, robotic 3D bio-printing, and 3D printed prosthesis are disruptive technologies that are in the early stages of application and should be tracked closely. Sharps disposal containers, biomedical 3D printing, and tooth 3D printing are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bio-compatible surgical adjuncts and bio-active prosthesis sealing, which are now well established in the industry.
Innovation S-curve for environmental sustainability in the medical devices industry
Bio-active prosthesis sealing is a key innovation area in environmental sustainability
Bio-active prosthesis sealing refers to a biological seal formed of soft tissue bio-active material surrounding the implant. The seal creates a biological barrier around the prosthesis to guard against infection. Further, these bioactive materials also help induce the regeneration and repair of tissues by producing only specific bonds.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 40+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of bio-active prosthesis sealing.
Key players in bio-active prosthesis sealing – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to bio-active prosthesis sealing
Company | Total patents (2010 - 2021) | Premium intelligence on the world's largest companies |
AbbVie | 55 | Unlock company profile |
Medtronic | 47 | Unlock company profile |
Merz PharmaaA | 29 | Unlock company profile |
Spotlight Technology Partners | 26 | Unlock company profile |
Croma-Pharma | 25 | Unlock company profile |
Mati Therapeutics | 22 | Unlock company profile |
Orthopaedic Innovation Centre | 21 | Unlock company profile |
Teijin | 20 | Unlock company profile |
Becton Dickinson and Co | 15 | Unlock company profile |
Kona Gold Beverage | 14 | Unlock company profile |
Johnson & Johnson | 14 | Unlock company profile |
P&R | 13 | Unlock company profile |
Hkl Medical | 13 | Unlock company profile |
Ministry of Trade and Industry, Singapore | 9 | Unlock company profile |
Klox Technologies | 9 | Unlock company profile |
QLT Plug Delivery | 9 | Unlock company profile |
Tyco Healthcare Group | 9 | Unlock company profile |
Fujifilm Holdings | 7 | Unlock company profile |
Integra LifeSciences Holdings | 7 | Unlock company profile |
Abbott Laboratories | 7 | Unlock company profile |
Bezwada Biomedical | 7 | Unlock company profile |
Halscion | 7 | Unlock company profile |
Singapore Health Services | 6 | Unlock company profile |
Omeros | 5 | Unlock company profile |
ODIN Biotech Partners | 5 | Unlock company profile |
Reflex Medical | 5 | Unlock company profile |
Source: GlobalData Patent Analytics
EW Healthcare Partners is one of the leading patent filers in bio-active prosthesis sealing. Some other leading patent filers include Johnson & Johnson and Medtronic.
In terms of application diversity, Coloplast leads the pack, followed by QLT Plug Delivery and Mati Therapeutics. By means of geographic reach, Venarum Medical holds the top position, followed by Adient Medical and Micell Technologies in the second and third spots, respectively.
The bioactive sealing material establishes a strong bond between the implant and the tissue, which doesn’t allow any bacteria or toxin to pass through the implant-tissue contact due to the bio-seals' strong sealant integrity. Bio-active sealing materials have garnered a great amount of attention, owing to their stability and integration. For instance, bioactive glass is becoming an important component in the field of dental implants.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.